FDA Inspection 826068 — Molecular NeuroImaging, LLC
The FDA completed an inspection of Molecular NeuroImaging, LLC on Apr 5, 2013 in New Haven, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Haven, CT (United States)
Additional Details
Sponsor, Contract Research Organization